Haicheung Pharmaceutical shareholders reduce 8.025 million share of total equity 5%

Haicheung Pharmaceutical (002099) Tuesday evening Notice that since the last performance of the report on the implementation of the changes in the disclosure obligation to close November 8, the company's shareholders Shanghai Fosun Chemical and Pharmaceutical Investment Co., Ltd. and its concerted action people Chongqing Pharmaceutical Industry Research Institute Limited Liability company accumulated reduction of 8.025 million shares, accounting for 5% of total equity.　　Among them, Fosun Chemical cumulative sale of the company shares 7.9003 million shares, accounting for 4.92% of the company's total equity, Chongqing Hospital, the cumulative sale of 124,700 shares, accounting for the company's total capital of 0.08%.　　After the reduction, Fosun chemical and its concerted action people Chongqing Medical Engineering Institute Total holding 9.1501 million shares of the company, accounting for 5.7% of total shares. Haicheung pharmaceutical industry closed at 28.21 Yuan in Tuesday, down 1.71%.